Cc1ccc(-c2noc(Cn3cnc4c(cnn4-c4ccccc4)c3=O)n2)cc1结构式
|
常用名 | Cc1ccc(-c2noc(Cn3cnc4c(cnn4-c4ccccc4)c3=O)n2)cc1 | 英文名 | 5-{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}-1-phenyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one |
|---|---|---|---|---|
| CAS号 | 1189450-17-6 | 分子量 | 384.4 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C21H16N6O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 5-{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}-1-phenyl-1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one |
|---|
| 分子式 | C21H16N6O2 |
|---|---|
| 分子量 | 384.4 |
| InChIKey | HIQMAJIPIZBZSO-UHFFFAOYSA-N |
| SMILES | Cc1ccc(-c2noc(Cn3cnc4c(cnn4-c4ccccc4)c3=O)n2)cc1 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|